Latest Breaking News On - Mayo clinic cancer centers arizona - Page 1 : comparemela.com

Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights News provided by Share this article SAN DIEGO, Feb. 25, 2021 /PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced recent company highlights and financial results for the fourth quarter and full year ended December 31, 2020. Over the last several months we achieved key clinical milestones, which provided the momentum for our successful raise of over $100 million. Together, these events have enabled us to accelerate the execution of our clinical programs and expand our pipeline to other relevant cancer indications, said Dr. Mark Erlander, chief executive officer of Cardiff Oncology. Data from our lead KRAS-mutated metastatic color

United statesUniversity of nebraska medical centerKaren osheaMark erlanderVicki kelemenJoyce allaireAmerican society of hematologyProstate cancer foundation scientificLifesci communicationsKansas universityCardiff oncology incNetwork developmentMikroscan technologies incUnetech instituteCrc programMassachusetts institute of technology